Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Original Article

A.C. Spyropoulos, W. Ageno, G.W. Albers, C.G. Elliott, J.L. Halperin, W.R. Hiatt, G.A. Maynard, P.G. Steg, J.I. Weitz, E. Suh, T.E. Spiro, E.S. Barnathan, and G.E. Raskob

N Engl J Med 2018;379:1118-1127

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
09/19/2018
Course expires: 
09/20/2020

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, September 20, 2020 - 11:59pm.